EMCDDA points out the need to address late diagnosis for hepatitis C among people who use drugs

Quinta-feira, 20 Setembro 18 00:00

As the main goal, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) wants to “provide evidence for better decisions and for action, for policy makers and for practitioners”. In an interview for News Farma, Alexis Goosdeel presents the major focus of action for the organization, based in Lisbon since 1994.

Por favor faça login ou registe-se para aceder a este conteúdo